filmov
tv
Advancing Cancer Research with Multiomics
Показать описание
Learn how researchers at the Ontario Institute for Cancer Research and United Health Network are linking the causes and consequences of complex phenotypes through multiomics to enable discoveries that weren’t possible before.
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
*Data calculations on file. Illumina, Inc., 2015.
View customer spotlight videos
View Illumina webinars
View Illumina product videos
View Illumina support videos
#ngs #multiomics #cancerresearch #OICR #UHN #illumina #sequencingbysynthesis #sbs #nextgenerationsequencing #genome #transcriptome #epigenome #proteome #Methylome #methylation #dna #rna #CancerSequencing
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
*Data calculations on file. Illumina, Inc., 2015.
View customer spotlight videos
View Illumina webinars
View Illumina product videos
View Illumina support videos
#ngs #multiomics #cancerresearch #OICR #UHN #illumina #sequencingbysynthesis #sbs #nextgenerationsequencing #genome #transcriptome #epigenome #proteome #Methylome #methylation #dna #rna #CancerSequencing
0:02:29
0:03:26
0:43:48
0:51:29
0:33:31
0:03:16
0:25:23
0:26:15
0:37:59
0:07:00
0:37:45
2:10:39
0:39:23
0:16:53
0:44:17
0:45:14
1:00:40
0:56:37
0:46:24
1:03:57
0:59:36
1:00:40
1:06:05
0:59:54